These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10202849)

  • 1. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
    Holmes BB; Rady JJ; Smith DJ; Fujimoto JM
    Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin.
    Rady JJ; Holmes BB; Fujimoto JM
    Proc Soc Exp Biol Med; 1999 Mar; 220(3):178-83. PubMed ID: 10193446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin.
    Rady JJ; Lin W; Fujimoto JM
    J Pharmacol Exp Ther; 1998 Mar; 284(3):878-85. PubMed ID: 9495845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of supraspinal and spinal CCK receptors in the modulation of antinociception induced by cold water swimming stress in the mouse.
    Suh HW; Song DK; Kwon SH; Kim KW; Min BH; Kim YH
    Neuropeptides; 1996 Aug; 30(4):379-84. PubMed ID: 8914865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
    Suh HW; Kim YH; Choi YS; Song DK
    Peptides; 1995; 16(7):1229-34. PubMed ID: 8545243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice.
    Rady JJ; Fujimoto JM
    J Pharmacol Exp Ther; 2001 Nov; 299(2):659-65. PubMed ID: 11602679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of spinal cholecystokininB receptors in mediating neurotensin hyperalgesia from the medullary nucleus raphe magnus in the rat.
    Urban MO; Smith DJ; Gebhart GF
    J Pharmacol Exp Ther; 1996 Jul; 278(1):90-6. PubMed ID: 8764339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE; Mayer DJ
    Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil.
    Urban MO; Jiang MC; Gebhart GF
    Brain Res; 1996 Oct; 737(1-2):83-91. PubMed ID: 8930354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
    Holmes BB; Fujimoto JM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
    Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
    Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.
    Singh L; Oles RJ; Field MJ; Atwal P; Woodruff GN; Hunter JC
    Br J Pharmacol; 1996 Jul; 118(5):1317-25. PubMed ID: 8818359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
    Rady JJ; Campbell WB; Fujimoto JM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):7-14. PubMed ID: 11123356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
    Rady JJ; Holmes BB; Fujimoto JM
    Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE; Mayer DJ
    Pain; 1991 Nov; 47(2):221-229. PubMed ID: 1762818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
    Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG
    Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF; Hewett K; Dickenson AH
    Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray.
    Netto CF; Guimarães FS
    Neuropsychopharmacology; 2004 Jan; 29(1):101-7. PubMed ID: 14583742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.